Patient P-02200
Synthetic patientMETA-24 · Day 175 · 35–44 · F · baseline S13Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
14%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S13
- Day 16 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 22 HY-01 recommended — Hydration Protocol HY-01
- Day 23 Patient declined — Not now
What changed?
Trajectory began diverging from predicted response on Day 16.
Primary contributors, last 14 days
- Treatment adherence-4
- Toxicity+4
What helped?
- Hydration Protocol HY-01Day 22Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable47 min
stable · +1.9 vs previous 14 d
Sleep duration
Wearable7.8 h
stable · +0.1 vs previous 14 d
Energy level
Daily log6.5/10
stable · -0.2 vs previous 14 d
Steps
Wearable6,084
improving · +404 vs previous 14 d
GI burden
Companion21.1/100
improving · -4.2 vs previous 14 d
Adherence
Companion93.8 %
stable · +3.1 vs previous 14 d
Sleep quality
Wearable58/100
stable · +1.3 vs previous 14 d
Glucose, CGM daily mean
CGM135 mg/dL
stable · -0.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading drifting · 67 from the failing basin, 32 from restoration.
Good elements to keep
- Protein (supports)perturbation · steering +6.4
- Proteinsupporter · GI -3.7 next day
Main detractors to watch
- Low butyrate capacityhidden · steering -17.5
- FUT2 non-secretorhidden · steering -10.6
- Low microbial diversityhidden · steering -7.7
- Bacteroides fragilis elevatedhidden · steering -7.4
- Ultra-processed fooddetractor · GI +3.4 next day
- Histamine loaddetractor · GI +2.5 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.7supporter · 95%
- Ultra-processed food+3.4detractor · 95%
- Histamine load+2.5detractor · 82%
- Simple carbohydrates+2detractor · 57%
- Dietary fat load+1.9detractor · 65%
- Insoluble fibre-1.4no signal · 38%
- Caffeine-0.4no signal · 15%
- Alcohol+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓60
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 30/100
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Intermediate metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
Microbiome
Shannon diversity 2.2 · butyrate capacity 30/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 37 ms
- Sleep
- 7.3 h
- Steps
- 6,256
- Resting HR
- 62 bpm
Daily log: GI score 21, nutritional resilience 66, adherence 94.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02513 | 55% | S16 | GI-04 | no change | 46 |
| P-02169 | 54% | S17 | — | — | 43 |
| P-02033 | 52% | S06 | GI-04 | improved | 51 |
| P-02223 | 51% | S20 | HY-01 | improved | 49 |
| P-02573 | 51% | S10 | — | — | 52 |
| P-02219 | 50% | S13 | — | — | 60 |
| P-02303 | 50% | S15 | GI-04 | improved | 48 |
| P-02339 | 50% | S03 | DT-01 | improved | 50 |
| P-02058 | 49% | S05 | GI-04 | no change | 48 |
| P-02262 | 49% | S16 | — | — | 53 |
| P-02336 | 49% | S20 | — | — | 50 |
| P-02417 | 49% | S18 | DT-01 | no change | 55 |